Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio
December 12, 2022 at 15:05 PM EST
Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
